Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study.

Recent studies suggest that inhaled corticosteroids can adversely affect bone metabolism. The objective of this study was to evaluate the importance of these adverse effects in a case-control study. Bone mineral density (BMD) was measured in 48 asthmatic adults (15 males and 33 females) treated with inhaled steroids (beclomethasone or budesonide) and in 48 gender and age-matched healthy subjects at baseline and at 2 yrs. Vertebral BMD was measured by dual energy X-ray densitometry. Patients had been treated with a dose of 662 +/- 278 micrograms (range 300-1,000 micrograms) of beclomethasone dipropionate or budesonide for more than 1 yr (mean duration of treatment 10.6 yrs, range 1-16 yrs). Twenty four patients had needed 1-6 short courses of oral steroids and seven had received oral corticosteroids (mean daily dose 6.2 mg prednisone) for 2-15 yrs more than 4 yrs prior to the BMD measurements. During the follow-up, 14 patients required 1-3 short courses of oral steroids. There was no correlation either between inhaled corticosteroid doses or duration of treatment and BMD values. There were no significant differences in BMD baseline values between patients and healthy controls. BMD significantly decreased in both groups at 2 yrs, from 1.08 +/- 0.19 to 1.05 +/- 0.19 g.cm-2 (p = 0.002) in asthmatics versus 1.12 +/- 0.17 to 1.09 +/- 0.18 g.cm-2 (p = 0.008) in controls. There were no significant differences in BMD loss between patients and healthy controls. Furthermore, no differences were found in bone loss when pre- and postmenopausal women were compared with their healthy control counterparts. No differences in baseline BMD were found between patients who had received regular oral corticosteroid therapy or booster courses of oral corticosteroids and those who had not. Inhaled corticosteroid treatment at a mean dose of 662 micrograms.day-1 and sporadic booster courses of oral corticosteroids do not further increase bone mass loss with respect to that expected from natural bone mass loss.

[1]  S. Johansson,et al.  Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover , 2004, European Journal of Clinical Pharmacology.

[2]  D. Bauer,et al.  Axial Bone Mass in Older Women , 1996, Annals of Internal Medicine.

[3]  M. Preece,et al.  Nocturnal cortisol secretion in healthy adults before and after inhalation of budesonide. , 1996, American journal of respiratory and critical care medicine.

[4]  J. Souberbielle,et al.  Inhaled beclomethasone and bone metabolism in young asthmatic children: a six month study. , 1995, The Journal of allergy and clinical immunology.

[5]  J. Baskerville,et al.  Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma. , 1995, The Journal of allergy and clinical immunology.

[6]  Jacques P. Brown,et al.  Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism. , 1994, The Journal of allergy and clinical immunology.

[7]  R. Hopp,et al.  Bone mineral density in normal and asthmatic children. , 1994, The Journal of allergy and clinical immunology.

[8]  D. Postma,et al.  Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group. , 1994, Thorax.

[9]  E. Baraldi,et al.  Effect of beclomethasone dipropionate on bone mineral content assessed by X-ray densitometry in asthmatic children: a longitudinal evaluation. , 1994, The European respiratory journal.

[10]  P. V. van Riel,et al.  Low-Dose Prednisone Induces Rapid Reversible Axial Bone Loss in Patients with Rheumatoid Arthritis , 1993, Annals of Internal Medicine.

[11]  B. Lask.  International Consensus Report on Diagnosis and Management of Asthma , 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  R. Pauwels.  The international consensus report on the diagnosis and management of asthma , 1993 .

[13]  R. Sorva,et al.  Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma. , 1992, The Journal of allergy and clinical immunology.

[14]  J. Douglas,et al.  Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. , 1992, Thorax.

[15]  D. Morrison,et al.  Bone turnover during short course prednisolone treatment in patients with chronic obstructive airways disease. , 1992, Thorax.

[16]  G. Rizzato,et al.  The reversibility of exogenous corticosteroid-induced osteoporosis , 1992 .

[17]  M. Prummel,et al.  Beclomethasone inhalation decreases serum osteocalcin concentrations. , 1991, BMJ.

[18]  S. Capewell,et al.  Bone turnover during high dose inhaled corticosteroid treatment. , 1991, Thorax.

[19]  Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report. , 1991, The Journal of allergy and clinical immunology.

[20]  C. Polman,et al.  Corticosteroids and bone mass. , 1990, Annals of internal medicine.

[21]  J. Eisman,et al.  Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. , 1989, Annals of the rheumatic diseases.

[22]  E. Bergstralh,et al.  Reversibility of steroid-induced osteoporosis. , 1988, The American journal of medicine.

[23]  P. Tothill,et al.  Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. , 1986, British medical journal.

[24]  J. Eisman,et al.  Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. , 1986, Annals of the rheumatic diseases.

[25]  M. Preece,et al.  NOCTURNAL ADRENAL SUPPRESSION IN ASTHMATIC CHILDREN TAKING INHALED BECLOMETHASONE DIPROPIONATE , 1986, The Lancet.

[26]  M. Hodson,et al.  Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function. , 1983, Thorax.

[27]  Zanten,et al.  Effects of short term and long term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction , 2022 .